Aspect Biosystems to Present on Liver and Pancreatic Tissue Therapeutics at American Society of Gene & Cell Therapy 25th Annual Meeting
Two posters and one oral presentation at ASGCT 2022 will highlight the development of Aspect’s bioengineered pancreatic and liver tissue therapeutics VANCOUVER, BC — Aspect Biosystems (“Aspect”), a biotechnology company… Read More




